Dale E. Bredesen, MD

Dale E. Bredesen, MD, received his undergraduate degree from Caltech and his medical degree from Duke University. He was a postdoctoral fellow in the laboratory of Nobel laureate Professor Stanley Prusiner and subsequently held faculty positions at UCSF, UCLA, and UCSD. 

Dr. Bredesen was the Founding President and CEO of the Buck Institute for Research on Aging. His laboratory studied the mechanisms of neurodegeneration and published more than 230 scientific papers, leading to the first publication of the reversal of cognitive decline in Alzheimer’s disease and two successful clinical trials. 

Dr. Bredesen is the author of three New York Times bestsellers and is currently Senior Director of the first precision medicine program for neurodegenerative diseases at the Pacific Neuroscience Institute.